DBVE-PC regimen: Difference between revisions

	WikiDoc Resources for DBVE-PC regimen
Articles
Most recent articles on DBVE-PC regimen Most cited articles on DBVE-PC regimen Review articles on DBVE-PC regimen Articles on DBVE-PC regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on DBVE-PC regimen Images of DBVE-PC regimen Photos of DBVE-PC regimen Podcasts & MP3s on DBVE-PC regimen Videos on DBVE-PC regimen
Evidence Based Medicine
Cochrane Collaboration on DBVE-PC regimen Bandolier on DBVE-PC regimen TRIP on DBVE-PC regimen
Clinical Trials
Ongoing Trials on DBVE-PC regimen at Clinical Trials.gov Trial results on DBVE-PC regimen Clinical Trials on DBVE-PC regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on DBVE-PC regimen NICE Guidance on DBVE-PC regimen NHS PRODIGY Guidance FDA on DBVE-PC regimen CDC on DBVE-PC regimen
Books
Books on DBVE-PC regimen
News
DBVE-PC regimen in the news Be alerted to news on DBVE-PC regimen News trends on DBVE-PC regimen
Commentary
Blogs on DBVE-PC regimen
Definitions
Definitions of DBVE-PC regimen
Patient Resources / Community
Patient resources on DBVE-PC regimen Discussion groups on DBVE-PC regimen Patient Handouts on DBVE-PC regimen Directions to Hospitals Treating DBVE-PC regimen Risk calculators and risk factors for DBVE-PC regimen
Healthcare Provider Resources
Symptoms of DBVE-PC regimen Causes & Risk Factors for DBVE-PC regimen Diagnostic studies for DBVE-PC regimen Treatment of DBVE-PC regimen
Continuing Medical Education (CME)
CME Programs on DBVE-PC regimen
International
DBVE-PC regimen en Espanol DBVE-PC regimen en Francais
Business
DBVE-PC regimen in the Marketplace Patents on DBVE-PC regimen
Experimental / Informatics
List of terms related to DBVE-PC regimen

VisualWikitext

Revision as of 14:22, 27 February 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: ABVE-PC Regimen; Adriamycin-Bleomycin-Vincristine-Etoposide/Prednisone-Cyclophosphamide Regimen; DBVE-PC; POG 9245 Regimen

Overview

DBVE-PC regimen refers to a regimen consisting of doxorubicin, bleomycin, vincristine, etoposide, prednisone and cyclophosphamide, given in combination with radiation therapy and used for the treatment of high-risk, childhood Hodgkin's lymphoma.^[1]^[2]

Regimen

C – Cyclophosphamide

Indications

High-risk, childhood Hodgkin's lymphoma

References

[1] "NCI Thesaurus".

[2] "R-CHOP - National Cancer Institute".

[1]

[2]

@@ Line 22: / Line 22: @@
 ==Indications==
-* [[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma, untreated]]<ref>{{Cite journal | doi = 10.1056/NEJMoa011795 | issn = 1533-4406 | volume = 346 | issue = 4 | pages = 235–242 | last = Coiffier | first = Bertrand | coauthors = Eric Lepage, Josette Briere, Raoul Herbrecht, Hervé Tilly, Reda Bouabdallah, Pierre Morel, Eric Van Den Neste, Gilles Salles, Philippe Gaulard, Felix Reyes, Pierre Lederlin, Christian Gisselbrecht | title = CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma | journal = The New England Journal of Medicine | date = 2002-01-24 | pmid = 11807147 }}</ref>
+* High-risk, childhood [[Hodgkin's lymphoma]]
-* [[Mantle cell lymphoma]]<ref>{{Cite journal | doi = 10.1056/NEJMoa1200920 | issn = 1533-4406 | volume = 367 | issue = 6 | pages = 520–531 | last = Kluin-Nelemans | first = H. C. | coauthors = E. Hoster, O. Hermine, J. Walewski, M. Trneny, C. H. Geisler, S. Stilgenbauer, C. Thieblemont, U. Vehling-Kaiser, J. K. Doorduijn, B. Coiffier, R. Forstpointner, H. Tilly, L. Kanz, P. Feugier, M. Szymczyk, M. Hallek, S. Kremers, G. Lepeu, L. Sanhes, J. M. Zijlstra, R. Bouabdallah, P. J. Lugtenburg, M. Macro, M. Pfreundschuh, V. Procházka, F. Di Raimondo, V. Ribrag, M. Uppenkamp, M. André, W. Klapper, W. Hiddemann, M. Unterhalt, M. H. Dreyling | title = Treatment of older patients with mantle-cell lymphoma | journal = The New England Journal of Medicine | date = 2012-08-09 | pmid = 22873532 }}</ref>
 ==References==